Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors
Open Access
- 1 February 1986
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 108 (2) , 305-311
- https://doi.org/10.1016/s0022-3476(86)81010-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Effects of ibuprofen, naproxen, and sulindac on prostaglandins in menKidney International, 1985
- Chlorpropamide action on renal concentrating mechanism in rats with hypothalamic diabetes insipidus.Journal of Clinical Investigation, 1983
- Tolmetin sodium in the management of nephrogenic diabetes insipidusThe Journal of Pediatrics, 1982
- Effects of indomethacin on intrarenal blood flow and meduliary osmoiality in dogsProstaglandins and Medicine, 1980
- Renal prostaglandin E2 in nephrogenic diabetes insipidus: Effects of inhibition of prostaglandin synthesis by indomethacinThe Journal of Pediatrics, 1980
- In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin.Journal of Clinical Investigation, 1977
- Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney.Journal of Clinical Investigation, 1975
- Development and Clinical Application of a New Method for the Radioimmunoassay of Arginine Vasopressin in Human PlasmaJournal of Clinical Investigation, 1973
- Nephrogenic Diabetes Insipidus: Effects of 3,5, Cyclic-adenosine MonophosphateArchives of Disease in Childhood, 1972
- Investigations into the Thiazide‐induced Antidiuresis in Patients with Diabetes InsipidusActa Medica Scandinavica, 1963